154 related articles for article (PubMed ID: 37627895)
1. Differential Protein Expression Patterns of HOXA13 and HOXB13 Are Associated with Bladder Cancer Progression.
Chin FW; Hussin H; Chau DM; Ong TA; Yunus R; Abdul Razack AH; Yusoff K; Chan SC; Veerakumarasivam A
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627895
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
Hu H; Chen Y; Cheng S; Li G; Zhang Z
Wien Klin Wochenschr; 2017 Jun; 129(11-12):391-397. PubMed ID: 27830363
[TBL] [Abstract][Full Text] [Related]
3. Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy.
Weiner AB; Faisal FA; Davicioni E; Karnes RJ; Griend DJV; Lotan TL; Schaeffer EM
Eur Urol Oncol; 2021 Dec; 4(6):955-962. PubMed ID: 32540218
[TBL] [Abstract][Full Text] [Related]
4. Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer.
Valizadeh S; Taghiyar S; Vahidi S; Abazari O; Akhavan Tafti M; Zavar Reza J
Biochem Genet; 2024 May; ():. PubMed ID: 38713442
[TBL] [Abstract][Full Text] [Related]
5. Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer.
Wang Y; He B; Dong Y; He GJ; Qi XW; Li Y; Yang YF; Rao Y; Cen ZS; Han F; Ding J; Li JJ
Cancer Biomark; 2021; 31(3):239-254. PubMed ID: 33896818
[TBL] [Abstract][Full Text] [Related]
6. An insight into the diagnostic and prognostic value of HOX A13's expression in non-muscle invasive bladder cancer.
Setti Boubaker N; Gurtner A; Trabelsi N; Manni I; Blel A; Saadi A; Chakroun M; Naimi Z; Zaghbib S; Ksontini M; Meddeb K; Rammeh S; Ayed H; Chebil M; Piaggio G; Ouerhani S
J Clin Lab Anal; 2022 Sep; 36(9):e24606. PubMed ID: 35853090
[TBL] [Abstract][Full Text] [Related]
7. HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.
Sui BQ; Zhang CD; Liu JC; Wang L; Dai DQ
Oncol Lett; 2018 Jun; 15(6):8833-8840. PubMed ID: 29928325
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.
Han Y; Tu WW; Wen YG; Li DP; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Med Oncol; 2013; 30(2):564. PubMed ID: 23592225
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.
Zhu JY; Sun QK; Wang W; Jia WD
Int J Clin Exp Pathol; 2014; 7(6):2925-33. PubMed ID: 25031711
[TBL] [Abstract][Full Text] [Related]
10. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
11. HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.
Varinot J; Furudoï A; Drouin S; Phe V; Penna RR; Roupret M; Bitker MO; Cussenot O; Compérat E
Virchows Arch; 2016 May; 468(5):619-22. PubMed ID: 26931741
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
Wang SS; Wuputra K; Liu CJ; Lin YC; Chen YT; Chai CY; Lin CS; Kuo KK; Tsai MH; Wang SW; Chen KK; Miyoshi H; Nakamura Y; Saito S; Hanafusa T; Wu DC; Lin CS; Yokoyama KK
Oncotarget; 2016 Jun; 7(24):36049-36064. PubMed ID: 27144338
[TBL] [Abstract][Full Text] [Related]
13. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease.
Habel LA; Sakoda LC; Achacoso N; Ma XJ; Erlander MG; Sgroi DC; Fehrenbacher L; Greenberg D; Quesenberry CP
Breast Cancer Res; 2013 Mar; 15(2):R24. PubMed ID: 23497539
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics.
Zhang R; Deng Y; Zhang Y; Zhai GQ; He RQ; Hu XH; Wei DM; Feng ZB; Chen G
Int J Clin Exp Pathol; 2017; 10(10):10650-10665. PubMed ID: 31966409
[TBL] [Abstract][Full Text] [Related]
15. A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer.
Ma XJ; Salunga R; Dahiya S; Wang W; Carney E; Durbecq V; Harris A; Goss P; Sotiriou C; Erlander M; Sgroi D
Clin Cancer Res; 2008 May; 14(9):2601-8. PubMed ID: 18451222
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma.
Pan TT; Jia WD; Yao QY; Sun QK; Ren WH; Huang M; Ma J; Li JS; Ma JL; Yu JH; Ge YS; Liu WB; Zhang CH; Xu GL
Tohoku J Exp Med; 2014 Nov; 234(3):209-19. PubMed ID: 25341685
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of HOXA13 in solid tumors: A meta-analysis.
Wen Y; Shu F; Chen Y; Chen Y; Lan Y; Duan X; Zhao SC; Zeng G
Clin Chim Acta; 2018 Aug; 483():64-68. PubMed ID: 29678634
[TBL] [Abstract][Full Text] [Related]
18. HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression.
Chang S; Liu J; Guo S; He S; Qiu G; Lu J; Wang J; Fan L; Zhao W; Che X
Oncol Rep; 2016 Jun; 35(6):3577-85. PubMed ID: 27108607
[TBL] [Abstract][Full Text] [Related]
19. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
Ma XJ; Hilsenbeck SG; Wang W; Ding L; Sgroi DC; Bender RA; Osborne CK; Allred DC; Erlander MG
J Clin Oncol; 2006 Oct; 24(28):4611-9. PubMed ID: 17008703
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
